These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37741882)

  • 21. Lithium Chloride Protects against Sepsis-Induced Skeletal Muscle Atrophy and Cancer Cachexia.
    Lee JH; Kim SW; Kim JH; Kim HJ; Um J; Jung DW; Williams DR
    Cells; 2021 Apr; 10(5):. PubMed ID: 33925786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and hydrophobicity at residue 132 on catalytic efficiency.
    Avellaneda Matteo D; Grunseth AJ; Gonzalez ER; Anselmo SL; Kennedy MA; Moman P; Scott DA; Hoang A; Sohl CD
    J Biol Chem; 2017 May; 292(19):7971-7983. PubMed ID: 28330869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of a novel mutant isocitrate dehydrogenase 1 inhibitor for glioma treatment.
    Zhang N; Zheng B; Yao X; Huang X; Du J; Shen Y; Huang Z; Chen J; Lin Q; Lan W; Lin W; Ma W
    Biochem Biophys Res Commun; 2021 Apr; 551():38-45. PubMed ID: 33714758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
    Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X
    Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
    Ying L; Yao Y; Lv H; Lu G; Zhang Q; Yang Y; Zhou J
    Am J Physiol Cell Physiol; 2022 May; 322(5):C814-C824. PubMed ID: 35319902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptomic analysis of the development of skeletal muscle atrophy in cancer-cachexia in tumor-bearing mice.
    Blackwell TA; Cervenka I; Khatri B; Brown JL; Rosa-Caldwell ME; Lee DE; Perry RA; Brown LA; Haynie WS; Wiggs MP; Bottje WG; Washington TA; Kong BC; Ruas JL; Greene NP
    Physiol Genomics; 2018 Dec; 50(12):1071-1082. PubMed ID: 30289747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release.
    Zhou L; Zhang T; Shao W; Lu R; Wang L; Liu H; Jiang B; Li S; Zhuo H; Wang S; Li Q; Huang C; Lin D
    Skelet Muscle; 2021 Jul; 11(1):17. PubMed ID: 34229732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small-Molecule Chemical Knockdown of MuRF1 in Melanoma Bearing Mice Attenuates Tumor Cachexia Associated Myopathy.
    Adams V; Gußen V; Zozulya S; Cruz A; Moriscot A; Linke A; Labeit S
    Cells; 2020 Oct; 9(10):. PubMed ID: 33050629
    [No Abstract]   [Full Text] [Related]  

  • 29. Group I Paks support muscle regeneration and counteract cancer-associated muscle atrophy.
    Cerquone Perpetuini A; Re Cecconi AD; Chiappa M; Martinelli GB; Fuoco C; Desiderio G; Castagnoli L; Gargioli C; Piccirillo R; Cesareni G
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):727-746. PubMed ID: 29781585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C/EBPβ promotes the expression of atrophy-inducing factors by tumours and is a central regulator of cancer cachexia.
    AlSudais H; Rajgara R; Saleh A; Wiper-Bergeron N
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):743-757. PubMed ID: 35014202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imperatorin alleviates cancer cachexia and prevents muscle wasting via directly inhibiting STAT3.
    Chen L; Xu W; Yang Q; Zhang H; Wan L; Xin B; Zhang J; Guo C
    Pharmacol Res; 2020 Aug; 158():104871. PubMed ID: 32413482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
    Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
    Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study.
    Luan Y; Zhang Y; Yu SY; You M; Xu PC; Chung S; Kurita T; Zhu J; Kim SY
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1289-1301. PubMed ID: 35044098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing Metabolic Dysregulation in Muscle During Cachexia.
    Hsu MY; Porporato PE; Wyart E
    Methods Mol Biol; 2019; 1928():337-352. PubMed ID: 30725463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia.
    Murphy KT; Chee A; Trieu J; Naim T; Lynch GS
    Dis Model Mech; 2012 Jul; 5(4):533-45. PubMed ID: 22563056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of ER stress and unfolding protein response pathways causes skeletal muscle wasting during cancer cachexia.
    Bohnert KR; Gallot YS; Sato S; Xiong G; Hindi SM; Kumar A
    FASEB J; 2016 Sep; 30(9):3053-68. PubMed ID: 27206451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myostatin is a novel tumoral factor that induces cancer cachexia.
    Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
    Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling the diffusion of D-2-hydroxyglutarate from IDH1 mutant gliomas in the central nervous system.
    Linninger A; Hartung GA; Liu BP; Mirkov S; Tangen K; Lukas RV; Unruh D; James CD; Sarkaria JN; Horbinski C
    Neuro Oncol; 2018 Aug; 20(9):1197-1206. PubMed ID: 29660019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
    Wang H; Lai YJ; Chan YL; Li TL; Wu CJ
    Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracerebral Distribution of the Oncometabolite d-2-Hydroxyglutarate in Mice Bearing Mutant Isocitrate Dehydrogenase Brain Tumors: Implications for Tumorigenesis.
    Pickard AJ; Sohn AS; Bartenstein TF; He S; Zhang Y; Gallo JM
    Front Oncol; 2016; 6():211. PubMed ID: 27781195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.